A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.
artículo científico publicado en 2011
A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.
artículo científico publicado en 2008
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients
artículo científico publicado en 2012
A new era for hepatitis C-new diagnostics tools and new weapons.
artículo científico publicado en 2012
A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients. The Hepatitis/HIV Spanish Study Group.
artículo científico publicado en 1997
A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.
artículo científico publicado en 2013
ACSM4 polymorphisms are associated with rapid AIDS progression in HIV-infected patients
artículo científico publicado en 2014
AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.
artículo científico publicado en 2018
Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
artículo científico publicado en 2002
Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner
artículo científico publicado en 2015
Adaptive cell immune response against the hepatitis C virus infection
artículo científico publicado en 2007
Addition of lamivudine to the drug regimen in patients with advanced HIV disease on nucleoside therapy
artículo científico publicado en 1997
Advances in hepatitis B therapeutics
artículo científico publicado en 2020
Advances in the diagnosis and treatment of the infection by the hepatitis B virus
artículo científico publicado en 2004
Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.
artículo científico
Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants
artículo científico publicado en 2007
An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study
artículo científico publicado en 2011
Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients.
artículo científico publicado en 2013
Analysis of pol Gene Heterogeneity, Viral Quasispecies, and Drug Resistance in Individuals Infected with Group O Strains of Human Immunodeficiency Virus Type 1
⬇️
artículo científico publicado el 1 de noviembre de 1998
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz
artículo científico publicado en 2004
Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.
artículo científico
Antiretroviral drugs and liver injury
artículo científico publicado en 2008
Antiretroviral drugs for pre-exposure prophylaxis of HIV infection
artículo científico publicado en 2012
Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.
artículo científico publicado en 2005
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome
artículo científico publicado en 2008
Antiviral effect of raltegravir on HTLV-1 carriers
artículo científico publicado en 2011
Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients
artículo científico publicado en 2011
Are fusion inhibitors active against all HIV variants?
artículo científico publicado en 2004
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?
artículo científico publicado en 2005
Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV
scientific article published on 01 May 1994
Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.
artículo científico publicado en 2013
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
artículo científico publicado en 2011
Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors
scientific article published on 01 August 1999
Association between tipranavir plasma levels and virological response in HIV-infected patients
artículo científico publicado en 2008
Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression
article
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
artículo científico publicado en 2010
Asymptomatic HIV
scientific article published on 01 November 1988
Atazanavir: the advent of a new generation of more convenient protease inhibitors
artículo científico publicado en 2005
Author's response: expert reviews: who are they for?
artículo científico publicado en 2012
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C
artículo científico publicado en 2008
Avoiding false-negative results for HTLV-II using new serological assays.
artículo científico publicado en 1995
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients
artículo científico publicado en 2007
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors
artículo científico publicado en 2006
Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens
⬇️
artículo científico publicado el 26 de marzo de 2012
CCR5 genotype and HIV-1 infection in perinatally-exposed infants
scientific article published on 01 January 1999
CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.
artículo científico publicado en 1999
CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy
artículo científico publicado en 2004
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study
article
CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation
artículo científico publicado en 2005
CD4+ T-cell gain with nonnucleoside or protease inhibitors: convenience may not always be the most convenient
artículo científico publicado en 2004
Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?
artículo científico publicado en 2003
Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?
artículo científico publicado en 2006
Cancer and deep venous thrombosis
artículo científico publicado en 1988
Cardiovascular disease risk in HIV infection and endothelial progenitor cells.
artículo científico publicado en 2012
Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
artículo científico publicado en 2008
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel
artículo científico publicado en 2007
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel
artículo científico publicado en 2005
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel
artículo científico publicado en 2002
Care of patients with hepatitis C and HIV co-infection
artículo científico publicado en 2004
Caution with new oral hepatitis C drugs.
artículo científico publicado en 2015
Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia
artículo científico publicado en 2013
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients
artículo científico publicado en 2011
Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain
artículo científico publicado en 2009
Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy
artículo científico publicado en 2013
Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy
artículo científico publicado en 2004
Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations
artículo científico publicado en 2005
Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients
artículo científico publicado en 2006
Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients
artículo científico publicado en 2003
Changes in the rate of genotypic resistance to antiretroviral drugs in Spain
artículo científico publicado en 2001
Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir
artículo científico publicado en 2008
Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain
artículo científico publicado en 2010
Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients
scientific article published on 01 July 2007
Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center
artículo científico publicado en 2005
Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation
artículo científico publicado en 2017
Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression
artículo científico publicado en 2011
Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate.
artículo científico publicado en 1997
Chemokine receptors and HIV-2
⬇️
artículo científico publicado el 15 de julio de 1997
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges
artículo científico publicado en 2006
Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond less
artículo científico publicado en 2006
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.
artículo científico publicado en 2013
Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group
artículo científico publicado en 2000
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
scientific article published on 01 January 2011
Clinical benefit of interventions driven by therapeutic drug monitoring
scientific article published on 01 September 2005
Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).
artículo científico publicado en 2009
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations
artículo científico publicado en 2004
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
artículo científico publicado en 2012
Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients
artículo científico publicado en 2006
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
artículo científico publicado en 2006
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial
artículo científico publicado en 2013
Combinations of nucleoside/nucleotide analogues for HIV therapy
artículo científico publicado en 2004
Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA ver
artículo científico publicado en 2001
Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assay
artículo científico publicado en 2011
Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon- for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial
⬇️
artículo científico publicado el 17 de julio de 2012
Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors
artículo científico publicado en 2002
Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
artículo científico publicado en 1999
Complications in treating chronic hepatitis B in patients with HIV.
artículo científico publicado en 2005
Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization.
artículo científico publicado en 2012
Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons
artículo científico publicado en 2006
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.
artículo científico publicado en 2004
Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain.
artículo científico publicado en 2008
Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing.
artículo científico publicado en 2010
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
artículo científico publicado en 2015
Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use
artículo científico publicado en 2007
Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests
artículo científico publicado en 2009
Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir
artículo científico publicado en 2003
Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals
artículo científico publicado en 2004
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
artículo científico publicado en 2007
Current concepts in the management and treatment of hepatitis C in HIV-infected patients.
artículo científico publicado en 2005
Current situation of human immunodeficiency virus type 2 and Human T lymphotropic virus in Spain
artículo científico publicado en 2010
Current status of HIV-2 and HTLV-1/2 infection in Spain: lights and shades
artículo científico publicado en 2005
Current trends in screening across ethnicities for hypersensitivity to abacavir
scientific article published on October 2008
Decline and changing profile of hepatitis delta among injection drug users in Spain.
artículo científico publicado en 2017
Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid
artículo científico publicado en 2002
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
artículo científico publicado en 2009
Detection of HTLV-II proviral sequences in HIV-immunosuppressed patients with HTLV indeterminate serological patterns
⬇️
artículo científico publicado el 1 de marzo de 1998
Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain
artículo científico publicado en 2010
Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms
⬇️
artículo científico publicado el 28 de marzo de 2012
Diabetes mellitus associated with protease inhibitor use
artículo científico publicado en 1999
Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.
artículo científico publicado en 2012
Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears.
artículo científico publicado en 1993
Diagnostic, clinical and therapeutic implications of viral hepatitides in HIV-infected patients
artículo científico publicado en 2006
Diarrhea related to lopinavir is most often mild and not related to plasma drug levels
artículo científico publicado en 2003
Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors
artículo científico publicado en 2002
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection
artículo científico publicado en 2004
Differences in lopinavir plasma concentrations comparing Kaletra film coated tablets and soft gelatine capsules that result in various lipid abnormalities.
artículo científico publicado en 2009
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe
artículo científico publicado en 2015
Differences in the length of gag proteins among different HIV type 1 subtypes.
artículo científico publicado en 2005
Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b.
artículo científico publicado en 2012
Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides
artículo científico publicado en 2002
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype.
artículo científico publicado en 2011
Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b.
artículo científico publicado en 2012
Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations
artículo científico publicado en 2004
Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs
artículo científico publicado en 2015
Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy
artículo científico publicado en 2005
Directly acting antivirals against hepatitis C virus
artículo científico publicado en 2011
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent
artículo científico publicado en 2006
Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.
artículo científico publicado en 2003
Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?
artículo científico publicado en 2010
Does an increase in nevirapine plasma levels cause complete virologic suppression in patients experiencing early virologic failure?
artículo científico publicado en 2002
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
artículo científico publicado en 2013
Dolutegravir for the treatment of HIV-2 infection
artículo científico publicado en 2015
Dolutegravir, abacavir and lamivudine as HIV therapy
artículo científico
Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy
artículo científico publicado en 2008
Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants
artículo científico publicado en 2010
Drug interactions in HIV-infected patients treated for hepatitis C.
artículo científico publicado en 2017
Drug interactions of tipranavir, a new HIV protease inhibitor
artículo científico publicado en 2007
Drug interactions with new hepatitis C oral drugs
artículo científico
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response.
artículo científico publicado en 2017
Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy
artículo científico publicado en 2010
Drug resistance mutations in patients infected with HIV-2 living in Spain
⬇️
artículo científico publicado el 10 de mayo de 2011
Dual antiretroviral therapy for HIV infection
artículo científico
Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
artículo científico
Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia
artículo científico publicado en 2010
Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy.
artículo científico publicado en 2007
Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy
artículo científico publicado en 2005
Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients
artículo científico publicado en 2005
Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia
artículo científico publicado en 2002
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study
artículo científico publicado en 2005
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma
artículo científico publicado en 2015
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort
artículo científico publicado en 2006
Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.
artículo científico publicado en 2013
Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure.
artículo científico publicado en 2010
Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study
artículo científico publicado en 2007
Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group
scientific article published on 01 July 1995
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
artículo científico publicado en 2008
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.
artículo científico publicado en 2014
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial
artículo científico publicado en 2007
Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter
artículo científico publicado en 2002
Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.
artículo científico publicado en 2006
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
artículo científico publicado en 2008
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients
artículo científico publicado en 2014
Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis
artículo científico publicado en 2010
Elite HIV controllers: myth or reality?
artículo científico publicado en 2007
Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.
artículo científico publicado en 2010
Emerging antiretroviral drugs
artículo científico publicado en 2013
Emerging challenges in managing hepatitis B in HIV patients
artículo científico
Emerging drugs for hepatitis C
artículo científico publicado en 2008
Emerging viral infections‑-a potential threat for blood supply in the 21st century.
artículo científico
Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.
artículo científico
Enfuvirtide is active against HIV type 1 group O.
artículo científico publicado en 2005
Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea
artículo científico publicado en 2004
Enhanced diagnostic efficiency of the polymerase chain reaction by co-amplification of multiple regions of HIV-1 and HIV-2
scientific article published on 01 August 1994
Enhancement of HIV antigen detection after acid dissociation of immune complexes is associated with loss of specificity
artículo científico publicado en 1995
Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group
artículo científico publicado en 1996
Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain. HTLV Spanish Study Group.
artículo científico publicado en 1996
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome
scientific article published on 12 January 2008
Escape mutations in HIV infection and its impact on CD8+ T cell responses
artículo científico publicado en 2007
Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.
artículo científico publicado en 2005
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database
artículo científico publicado en 2010
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
artículo científico publicado en 2008
European guideline for the management of hepatitis B and C virus infections, 2010.
artículo científico publicado en 2010
European guidelines on the clinical management of HIV-1 tropism testing
scientific article published on 21 March 2011
European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients.
artículo científico publicado en 2014
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
artículo científico publicado el 1 de abril de 2011
Evaluation of a new fluorescence immunoassay for CD4+ and CD8+ T cell counts in clinical samples
artículo científico publicado en 1994
Evaluation of a new saliva collection device for HIV antibody screening purposes
artículo científico publicado en 1994
Evaluation of different supplementary assays for the confirmation of HIV-1 and HIV-2 infections.
artículo científico publicado en 1994
Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes
artículo científico publicado en 2008
Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.
artículo científico publicado en 2008
Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses
artículo científico publicado en 2006
Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C.
artículo científico publicado en 2017
Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma.
artículo científico publicado en 2002
Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes
artículo científico publicado en 2004
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes
artículo científico publicado en 2008
Evidence of HIV-2 infection in Equatorial Guinea (central Africa): partial genetic analysis of a B subtype virus.
artículo científico publicado en 1997
Evidence of Nef Truncation in Human Immunodeficiency Virus Type 2 Infection
⬇️
artículo científico publicado el 1 de enero de 1998
Evolution of T-cell responses to hepatitis C virus (HCV) during pegylated interferon plus ribavirin treatment in HCV-monoinfected and in HCV/HIV-coinfected patients.
artículo científico publicado en 2007
Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure
artículo científico publicado en 2004
Evolution of the functional profile of HIV-specific CD8+ T cells in patients with different progression of HIV infection over 4 years
artículo científico publicado en 2010
Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor
artículo científico publicado en 2002
Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients
artículo científico
Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999
artículo científico publicado en 2002
Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.
artículo científico publicado en 2005
Faldaprevir and deleobuvir for HCV genotype 1 infection.
artículo científico publicado en 2013
Fatal varicella hepatitis in a patient with AIDS
artículo científico publicado en 1992
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome
scientific article published on 01 September 2009
First-line therapy and mitochondrial damage: different nucleosides, different findings
artículo científico publicado en 2003
Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program
artículo científico publicado en 2009
Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, Spain
artículo científico publicado en 2009
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
artículo científico publicado en 2010
From respiratory sensitization to food allergy: Anaphylactic reaction after ingestion of mushrooms (Agaricus bisporus).
artículo científico publicado en 2015
Gene Editing for HIV Cure at the Edge
scientific article published on 01 January 2019
Gene therapy for HIV infection.
artículo científico publicado en 2014
Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS.
artículo científico publicado en 1997
Genetic analysis of regulatory, promoter, and TAR regions of LTR sequences belonging to HIV type 1 Non-B subtypes
artículo científico publicado en 2005
Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression
scientific article published on 09 December 2006
Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools
artículo científico publicado en 2008
Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients
artículo científico publicado en 2013
Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia
scientific article published on 01 January 2007
Genetic mechanisms of resistance to NRTI and NNRTI.
artículo científico publicado en 2002
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors
artículo científico publicado en 2002
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction
artículo científico publicado en 2011
Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection
artículo científico publicado en 2014
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis
artículo científico publicado en 2015
Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients
⬇️
artículo científico publicado en 2010
Gynecomastia in HIV-infected patients receiving antiretroviral therapy
scientific article published on 01 September 2003
HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain
article
HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals
artículo científico publicado en 2011
HIV Gag-specific immune response mediated by double negative (CD3(+)CD4(-)CD8(-)) T cells in HIV-exposed seronegative individuals
artículo científico publicado en 2012
HIV and HCV coinfection
artículo científico publicado en 2006
HIV and Liver Disease
⬇️
artículo científico publicado el 3 de julio de 2012
HIV co-infection in HTLV-1 carriers in Spain
artículo científico publicado en 2019
HIV entry inhibitors: mechanisms of action and resistance pathways
artículo científico publicado en 2006
HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein
artículo científico publicado en 2013
HIV protease inhibitors: recent clinical trials and recommendations on use.
scientific article published on July 2009
HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionality
artículo científico publicado en 2008
HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors
artículo científico publicado en 2006
HIV type 2 epidemic in Spain: challenges and missing opportunities.
artículo científico publicado en 2017
HIV-1 causing AIDS and death in a seronegative individual
scientific article published on 01 January 1994
HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines
artículo científico publicado en 2009
HIV-1 infection in persistently HIV-1-seronegative individuals: more reasons for HIV RNA screening
artículo científico publicado en 2008
HIV-1 subtype J recombinant viruses in Spain
scientific article published on 01 May 2002
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
artículo científico
HIV-2 and HTLV-1/2 infections in Spain
artículo científico publicado en 2009
HIV-2 and HTLV-I/II infections in Spain
artículo científico publicado en 2004
HIV-2 in Spain.
artículo científico publicado en 1989
HIV-2 infection and human lymphotropic type 1 and type 2 virus in Spain
artículo científico publicado en 2007
HIV-2 infection in high-risk individuals with indeterminate HIV-1 western blot analysis: a serologic surveillance.
artículo científico publicado en 1992
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.
artículo científico publicado en 2004
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
artículo científico publicado en 2014
HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe
artículo científico publicado en 2003
HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy.
artículo científico publicado en 2013
HTLV infection among foreign pregnant women living in Spain
artículo científico publicado en 2011
HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
artículo científico publicado en 2005
HTLV infection in HCV-antibody positive patients in Spain
artículo científico publicado en 2017
HTLV testing of solid organ transplant donors
scientific article published on 08 October 2019
HTLV-1 infection and disease in Spain
artículo científico publicado en 2017
HTLV-1 infection in solid organ transplant donors and recipients in Spain
artículo científico publicado en 2019
HTLV-I and HTLV-II infections in Spain.
artículo científico publicado en 1993
HTLV-I/II infection among immigrants to Spain.
artículo científico publicado en 1994
HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)
artículo científico publicado en 2016
Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin
artículo científico publicado en 2005
Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis
artículo científico publicado en 2015
Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C.
artículo científico publicado en 2009
Hepatitis A Outbreaks in European Homosexual Men.
artículo científico publicado en 2017
Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
artículo científico publicado en 2009
Hepatitis B in HIV-infected patients
artículo científico
Hepatitis B vaccination: An unmet challenge in the era of harm reduction programs
artículo científico publicado en 2007
Hepatitis B virus escape mutants induced by antiviral therapy
artículo científico publicado en 2008
Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir
artículo científico publicado en 2008
Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients
artículo científico publicado en 2007
Hepatitis B virus infection despite receiving lamivudine in one HIV-infected person
artículo científico publicado en 2003
Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain
artículo científico publicado en 2013
Hepatitis B: treatment strategies and resistance
Hepatitis C cure with antiviral therapy--benefits beyond the liver
artículo científico
Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
artículo científico publicado en 2015
Hepatitis C therapy with HCV NS5B polymerase inhibitors
artículo científico publicado en 2013
Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver
artículo científico publicado en 2012
Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy.
artículo científico publicado en 2000
Hepatitis C viremia in HIV/HCV-coinfected patients: lower levels in presence of chronic hepatitis B.
artículo científico publicado en 2005
Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients
artículo científico publicado en 2004
Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients.
artículo científico publicado en 2004
Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy
artículo científico publicado en 2008
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression
artículo científico publicado en 2009
Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients
artículo científico publicado en 2015
Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves
artículo científico publicado en 2013
Hepatitis C virus resistance to the new direct-acting antivirals
artículo científico publicado en 2016
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients
artículo científico publicado en 2012
Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
artículo científico publicado en 2004
Hepatitis Delta Could Be More Frequent than Previously Thought
artículo científico publicado en 2018
Hepatitis Delta Enters a New Therapeutic Era.
artículo científico publicado en 2018
Hepatitis Delta Estimates in the United States Revisited
artículo científico publicado en 2019
Hepatitis E: an emerging viral disease
artículo científico publicado en 2014
Hepatitis delta and HIV infection
artículo científico publicado en 2017
Hepatitis delta in HIV-infected individuals in Europe
artículo científico publicado en 2011
Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients
artículo científico publicado en 2014
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C
artículo científico publicado en 2001
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome
artículo científico publicado en 2004
Hepatotoxicity after introduction of highly active antiretroviral therapy
scientific article published on 01 July 1998
Hepatotoxicity of antiretrovirals: incidence, mechanisms and management
artículo científico publicado en 2005
Heterogeneous nature of HIV-1 recombinants spreading in Spain
scientific article published on 01 March 2005
High alcohol intake and slow progression to AIDS.
artículo científico publicado en 1996
High morbidity and mortality of chronic viral liver disease in HIV-infected individuals in Spain
scientific article published on 01 January 1994
High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid
artículo científico publicado en 2002
High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor
artículo científico publicado en 2010
High rate of co-infection with different hepatitis C virus subtypes in HIV-infected intravenous drug addicts in Spain. Hepatitis HIV Spanish Study Group.
artículo científico publicado en 1995
High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART.
artículo científico publicado en 2006
High rate of resistance to antiretroviral drugs among HIV-infected prison inmates
artículo científico publicado en 2003
High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists
artículo científico publicado en 2010
High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.
artículo científico publicado en 2016
Higher antiviral activity of antiretroviral regimens including protease inhibitors.
artículo científico publicado en 1999
Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations
artículo científico publicado en 2004
Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.
artículo científico publicado en 2006
Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure
⬇️
artículo científico publicado el 1 de agosto de 2012
Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France
artículo científico publicado en 2016
Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C.
artículo científico publicado en 1998
Hospital outbreak of scabies stemming from two AIDS patients with Norwegian scabies
artículo científico publicado en 1990
Hospital-based surveillance for HTLV-1/2 infections in Spain
artículo científico publicado en 2007
Host factors involved in low susceptibility to HIV infection.
artículo científico publicado en 2011
Host genetics.
artículo científico publicado en 2011
Hot News
scholarly article
Hot News: Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure
artículo científico publicado en 2017
Hot News: Hepatitis B Gene Therapy Coming to Age
article
How effective is HAART in HCV and HIV coinfection?
artículo científico publicado en 2004
Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.
artículo científico publicado en 2007
Human T-cell lymphotropic virus infection in pregnant women in Spain.
artículo científico publicado en 1997
Human herpesvirus 6 in Spain: seroprevalence in blood donors and patients with lymphoproliferative disorders or HIV infection
scientific article published on 01 January 1991
Human immunodeficiency virus and liver disease: conference proceedings
scientific article published on 01 March 2010
Human immunodeficiency virus infection and viral hepatitis
artículo científico publicado en 2011
Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal.
artículo científico publicado en 2003
Human immunodeficiency virus type 2 (HIV-2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load
article
Human immunodeficiency virus type 2 and human T-cell lymphotropic virus type 1 and type 2 infections in Spain: an update
artículo científico publicado en 2009
Human immunodeficiency virus type 2 infection in Spain. The HIV-2 Spanish Study Group
artículo científico publicado en 1999
Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study
artículo científico publicado en 2011
Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients
artículo científico publicado en 2013
Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation
artículo científico publicado en 2007
Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy
artículo científico publicado en 2000
Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy
artículo científico publicado en 2003
Hypoglycemia in a diabetic patient during hepatitis C therapy.
artículo científico publicado en 2015
IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.
artículo científico publicado en 2015
IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians
artículo científico publicado en 2014
IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
artículo científico publicado en 2016
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
artículo científico publicado en 2011
IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients.
artículo científico publicado en 2012
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection
artículo científico publicado en 2015
Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library
artículo científico publicado en 2012
Idiopathic CD4+ T-lymphocytopenia
artículo científico publicado en 1992
Immediate hypersensitivity to heparins: a cross-reactivity study
artículo científico publicado en 2014
Immunizations in HIV-infected adults
artículo científico publicado en 2007
Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine
artículo científico publicado en 2006
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group
artículo científico publicado en 2011
Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients
artículo científico publicado en 2006
Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir
artículo científico publicado en 2002
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
artículo científico publicado en 2005
Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV
artículo científico publicado en 2012
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse
artículo científico publicado en 2011
Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C.
artículo científico publicado en 2017
Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia.
artículo científico publicado en 2010
Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years
artículo científico publicado en 2008
Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients
artículo científico publicado en 2011
Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.
artículo científico publicado en 2007
Impact of antiretroviral treatment-related toxicities on hospital admissions in HIV-infected patients
scientific article published on 01 September 2006
Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.
artículo científico publicado en 2011
Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients
artículo científico publicado en 2010
Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials
artículo científico publicado en 2007
Impact of chronic hepatitis C on HIV-1 disease progression
artículo científico publicado en 2004
Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.
artículo científico publicado en 1999
Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens
artículo científico publicado en 2004
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
artículo científico publicado en 2005
Impact of ethnicity and HIV type 1 subtype on response to first-line antiretroviral therapy
scientific article published on 01 July 2007
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes
artículo científico publicado en 2004
Impact of hepatitis C virus (HCV) on morbidity and mortality rates among HIV-infected patients
artículo científico publicado en 2003
Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT
artículo científico publicado en 2005
Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.
artículo científico publicado en 2011
Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C.
artículo científico publicado en 2005
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.
artículo científico publicado en 2010
Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools
artículo científico publicado en 2009
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study
artículo científico publicado en 2003
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy
article
Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine
artículo científico publicado en 2003
Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin
artículo científico publicado en 2008
Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain
artículo científico publicado en 2008
Increasing Impact of Chronic Viral Hepatitis on Hospital Admissions and Mortality among HIV-Infected Patients
⬇️
artículo científico publicado el 1 de noviembre de 2001
Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure
artículo científico publicado en 2003
Indinavir-induced thrombocytopenia
artículo científico publicado en 2003
Induction-maintenance (5 --> 3 drugs) in HIV-infected patients with high viral load.
artículo científico publicado en 2000
Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain
artículo científico publicado en 2005
Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II.
artículo científico publicado en 2002
Infections due to HIV-2 and HTLV-1/2 in Spain
artículo científico publicado en 2006
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects
artículo científico publicado en 2005
Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus
artículo científico publicado en 2007
Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.
artículo científico publicado en 2013
Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients
artículo científico publicado en 2005
Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection
artículo científico publicado en 2010
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
artículo científico publicado en 2005
Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients
artículo científico publicado en 2006
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
artículo científico publicado en 2011
Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis C
artículo científico publicado en 2007
Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user
artículo científico publicado en 2008
Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.
artículo científico publicado en 2006
Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain.
artículo científico publicado en 2009
Insufficiencies of the new WHO western blot criteria in the diagnosis of HIV-1 and HIV-2 infections
scientific article published on 01 January 1992
Integrase inhibitors.
artículo científico publicado en 2005
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection
artículo científico publicado en 2009
Intensification of antiretroviral therapy.
artículo científico publicado en 2001
Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients.
artículo científico publicado en 2000
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study
artículo científico publicado en 2014
Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients.
artículo científico publicado en 2013
Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.
artículo científico publicado en 2011
Intrapatient and Interpatient Pharmacokinetic Variability of Raltegravir in the Clinical Setting
Introduction of HIV drug-resistance testing in clinical practice
artículo científico publicado en 1999
Introduction of non-B subtypes among Spaniards newly diagnosed with HIV type 1 in the Canary Islands
artículo científico publicado en 2007
Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.
artículo científico publicado en 2014
Is HIV still a special population for the treatment of hepatitis C?
artículo científico publicado en 2016
Is Ribavirin Teratogenic in Humans? No Evidence So Far.
artículo científico publicado en 2017
Is natural conception a valid option for HIV-serodiscordant couples?
scientific article published on 19 July 2007
Is there a role for indinavir twice-daily in clinical practice?
scientific article published on 01 March 2000
Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
scientific article published on 01 July 2000
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
artículo científico publicado en 2005
Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes?
artículo científico publicado en 2003
Jérôme Lejeune passed away 25 years ago
scientific article published on 06 June 2019
Kaposi's sarcoma and disseminated tuberculosis in HIV-negative individual
artículo científico publicado en 1992
Keeping alive enterprises while embracing unprecedented COVID-19 restrictions
scientific article published on 01 January 2020
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
artículo científico publicado en 2009
LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression
artículo científico publicado en 1998
Lack of 'occult' hepatitis B virus infection in HIV-infected patients.
artículo científico publicado en 2002
Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses
artículo científico publicado en 2007
Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients
artículo científico publicado en 1998
Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.
artículo científico publicado en 2009
Lack of significant cross-reactivity for HIV-2 immunoblots in HIV-1-infected patients
artículo científico publicado en 2009
Lamivudine resistance in human T-cell leukemia virus type 1 may be due to a polymorphism at codon 118 (V-->I) of the reverse transcriptase
artículo científico publicado en 2003
Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C
article
Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)
⬇️
artículo científico publicado el 24 de abril de 2011
Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy
artículo científico publicado en 2002
Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis B Extensively Exposed to Antiretroviral Therapy with Anti-HBV Activity
article
Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons
artículo científico publicado en 2002
Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
artículo científico publicado en 2008
Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity
artículo científico publicado en 2006
Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy
artículo científico publicado en 2008
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients
artículo científico publicado en 2014
Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy.
artículo científico publicado en 2013
Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases
artículo científico publicado en 2007
Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.
artículo científico publicado en 2002
Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.
artículo científico publicado en 2013
Liver toxicity caused by nevirapine
artículo científico publicado en 2002
Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation?
artículo científico publicado en 2005
Long-acting antiretroviral therapy
scientific article published on 01 August 2020
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies.
artículo científico publicado en 2004
Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors
artículo científico publicado en 2011
Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes
artículo científico publicado en 2003
Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C.
artículo científico publicado en 2014
Longer Life Expectancy but still Accelerating Aging in HIV Patients under Antiretroviral Therapy
artículo científico publicado en 2018
Longitudinal assessment of interleukin 7 plasma levels in HIV-infected patients in the absence of and under antiretroviral therapy
artículo científico publicado en 2011
Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy
artículo científico
Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients
artículo científico publicado en 2003
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients
artículo científico publicado en 2013
Low risk of pancreatitis in HIV-infected patients on hydroxyurea plus didanosine.
artículo científico publicado en 2001
Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.
artículo científico publicado en 2010
Management and therapy of chronic hepatitis C in HIV.
artículo científico publicado en 2007
Management and treatment of chronic hepatitis B in HIV-positive patients
artículo científico publicado en 2014
Management and treatment of chronic hepatitis C in HIV patients
artículo científico
Management of chronic hepatitis B and C in HIV-coinfected patients
artículo científico publicado en 2006
Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.
artículo científico publicado en 2004
Management of chronic hepatitis C virus infection in HIV-infected patients
artículo científico publicado en 2008
Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.
artículo científico publicado en 2002
Management of hepatitis B virus co-infection on and off antiretroviral therapy
artículo científico publicado en 2008
Management of hepatitis C in HIV and/or HBV co-infected patients.
artículo científico
Management of hepatitis C in HIV-infected persons
⬇️
artículo científico publicado el 1 de noviembre de 2001
Management of metabolic complications and cardiovascular risk in HIV-infected patients
scientific article published on October 2010
Management of patients co-infected with hepatitis B virus and HIV.
artículo científico publicado en 2005
Measurement of Human Immunodeficiency Virus Type 1 Plasma Virus Load Based on Reverse Transcriptase (RT) Activity: Evidence of Variabilities in Levels of Virion‐Associated RT
⬇️
artículo científico publicado el 1 de mayo de 1998
Measurement of ribavirin plasma concentrations by high-performance liquid chromatography using a novel solid-phase extraction method in patients treated for chronic hepatitis C.
artículo científico publicado en 2007
Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir
artículo científico publicado en 2012
Mechanisms of resistance to antiretroviral drugs--clinical implications.
artículo científico publicado en 2002
Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma
artículo científico publicado en 2007
Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy
artículo científico publicado en 2007
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV.
artículo científico publicado en 2010
Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain
artículo científico publicado en 2006
Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain
artículo científico publicado en 2014
Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain
artículo científico publicado en 2005
Molecular evidence of homosexual transmission of HIV type 2 in Spain.
artículo científico publicado en 2001
Monthly cyclic therapy in heavily pretreated HIV-infected patients.
artículo científico publicado en 2001
Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus.
artículo científico publicado en 2001
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.
artículo científico publicado en 2005
Multifocal bone tuberculosis in one AIDS patient
⬇️
artículo científico publicado el 1 de agosto de 1992
Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity.
artículo científico publicado en 2009
Mycosis fungoides and Sezary syndrome are not associated with HTLV‐I infection: an international study
⬇️
artículo científico publicado el 1 de septiembre de 1997
Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients
artículo científico publicado en 2011
Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure
artículo científico publicado en 2006
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.
artículo científico publicado en 2006
Naturally occurring sequence polymorphisms within HIV type 1 group O protease.
artículo científico publicado en 2001
Need to Face Liver Cirrhosis after HCV Cure with Antivirals.
artículo científico publicado en 2017
Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations
artículo científico publicado en 2003
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial
article
New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B.
artículo científico publicado en 2011
New antivirals for the treatment of chronic hepatitis B.
artículo científico publicado en 2017
New findings on transcription regulation across different HIV-1 subtypes.
artículo científico publicado en 2006
New hepatitis C therapies for special patient populations
artículo científico publicado en 2015
New hopes for HIV and HCV coinfection in 2004.
artículo científico publicado en 2004
New human retrovirus
artículo científico publicado en 2010
New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients
artículo científico publicado en 2010
New paradigms in the management of HIV and hepatitis C virus coinfection
artículo científico publicado en 2005
New therapeutic strategies for raltegravir
artículo científico publicado en 2009
New therapies for hepatitis C virus infection
artículo científico publicado en 2009
No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
article
No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients
artículo científico publicado en 2012
No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors
artículo científico publicado en 2008
Non-Human Cancers in AIDS Patients
artículo científico publicado en 2015
Noncirrhotic portal hypertension in HIV infection
artículo científico publicado en 2011
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.
artículo científico publicado en 2010
Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy
artículo científico publicado en 2002
Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of ant
artículo científico publicado en 2011
Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection
artículo científico publicado en 2007
Nucleoside/nucleotide backbones for the treatment of HIV infection
artículo científico publicado en 2005
Obituary: HIV/AIDS researcher Mark Wainberg passed away
artículo científico publicado en 2017
Occult hepatitis B and HIV infection
scientific article published on 01 November 2019
Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study
artículo científico publicado en 2008
Optimal use of maraviroc in clinical practice
artículo científico publicado en 2008
Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
⬇️
artículo científico publicado el 19 de marzo de 2010
Outbreak of syphilis, but not of acute hepatitis C, among HIV-infected homosexual men in Madrid
article
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation.
artículo científico publicado en 2009
Overview of the pharmacogenetics of HIV therapy.
artículo científico publicado en 2006
PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy.
artículo científico publicado en 2014
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine
artículo científico publicado en 2005
Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
artículo científico publicado en 2003
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.
artículo científico publicado en 2013
Performance of Six Different Ritonavir-Boosted Protease Inhibitor–Based Regimens in Heavily Antiretroviral-Experienced HIV-Infected Patients
article
Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters
artículo científico publicado en 2008
Performance of drug resistance assays in testing HIV-1 non-B subtypes.
artículo científico publicado en 2003
Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants
artículo científico publicado en 2008
Pharmacogenetics in HIV therapy.
artículo científico publicado en 2005
Pharmacogenetics of antiretroviral therapy
artículo científico publicado en 2014
Pharmacogenetics of hepatitis C.
artículo científico publicado en 2011
Pharmacogenetics of tenofovir treatment
scientific article published on October 2009
Pharmacokinetics of new oral hepatitis C antiviral drugs
⬇️
artículo científico publicado el 25 de octubre de 2012
Pharmacokinetics, interactions and mechanism of action of maraviroc
artículo científico publicado en 2008
Phase I study of mitonafide in solid tumors
artículo científico publicado el 1 de agosto de 1992
Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy
artículo científico publicado en 2003
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues
artículo científico publicado en 2008
Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.
artículo científico publicado en 2011
Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C
artículo científico publicado en 2010
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1
artículo científico publicado en 2006
Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations
artículo científico publicado en 2011
Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance
artículo científico publicado en 2010
Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain
artículo científico publicado en 2011
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
artículo científico publicado en 2011
Prediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotient
artículo científico publicado en 2004
Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
artículo científico publicado en 2007
Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients
artículo científico publicado en 2005
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus
artículo científico publicado en 2019
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
artículo científico publicado en 2010
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study
artículo científico publicado en 2009
Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
artículo científico publicado en 2006
Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations
artículo científico publicado en 2004
Predictors of virological response to atazanavir in protease inhibitor-experienced patients
artículo científico publicado en 2004
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C.
artículo científico publicado en 2010
Preexposure prophylaxis in the prevention of HIV infection
artículo científico publicado en 2011
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.
artículo científico publicado en 2007
Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain
article
Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients.
artículo científico publicado en 2001
Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance
artículo científico publicado en 2008
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.
artículo científico publicado en 2018
Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up.
artículo científico publicado en 2012
Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients
artículo científico publicado en 2007
Prevalence of G333D/E in naive and pretreated HIV-infected patients
artículo científico publicado en 2002
Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain
artículo científico publicado en 2004
Prevalence of HTLV infection in pregnant women in Spain
artículo científico publicado en 2000
Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey
⬇️
artículo científico publicado el 1 de agosto de 2010
Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy
artículo científico publicado en 2007
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance
artículo científico publicado en 2007
Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.
artículo científico publicado en 2008
Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors
scientific article published on 23 July 2007
Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues
artículo científico publicado en 2004
Prevalence of drug-resistant HIV-1 genotypes in heavily pre-treated patients on current virological failure
scientific article published on 01 July 2000
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
artículo científico publicado en 2005
Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors
artículo científico publicado en 2007
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain
article
Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group
⬇️
artículo científico publicado el 1 de julio de 1995
Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.
artículo científico publicado en 2001
Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain.
artículo científico publicado en 1995
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor
artículo científico publicado en 2012
Prevalence of the HIV protease mutation N88S causing hypersensitivity to amprenavir
artículo científico publicado en 2002
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance
scientific article published on 01 April 2006
Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
artículo científico publicado en 2012
Prevention and management of treatment failure to new oral hepatitis C drugs.
artículo científico publicado en 2016
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids
artículo científico publicado en 2000
Primary lymphoma of the central nervous system and HTLV-I infection
artículo científico publicado en 2002
Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients
artículo científico publicado en 2010
Prioritization of new oral hepatitis C therapies for HIV patients
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
artículo científico publicado en 2008
Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies
artículo científico publicado en 2014
Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1).
artículo científico publicado en 2006
RNA viruses at the forefront of human infections - HIV, hepatitis C, and now Ebola
artículo científico publicado en 2014
Raltegravir and etravirine are active against HIV type 1 group O.
artículo científico publicado en 2009
Rapid Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O
scientific article published in 2003
Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.
artículo científico publicado en 2002
Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor
artículo científico publicado en 2003
Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals
⬇️
scientific article published on 01 January 2019
Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C.
artículo científico publicado en 2015
Rate and predictors of success in the retreatment of chronic hepatitis C virus in HIV/hepatitis C Virus coinfected patients with prior nonresponse or relapse
artículo científico publicado en 2010
Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials
artículo científico publicado en 2016
Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients
artículo científico publicado en 2009
Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.
artículo científico publicado en 2006
Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain
artículo científico publicado en 2002
Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy
artículo científico publicado en 2003
Reactivation of Hepatitis B in HIV Patients Treated for Hepatitis C.
artículo científico publicado en 2016
Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection
article
Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection
article
Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS
artículo científico publicado en 2018
Recombinant human immunodeficiency viruses type 1 circulating in Spain.
artículo científico publicado en 2000
Recomendaciones españolas sobre el uso adecuado de enfuvirtida
artículo científico publicado en 2007
Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
artículo científico publicado en 2006
Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activity
artículo científico publicado en 2005
Regression of Invasive AIDS‐Related Kaposi's Sarcoma Following Antiretroviral Therapy
article
Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin
artículo científico publicado en 2006
Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection
artículo científico publicado en 2005
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
artículo científico publicado en 2016
Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections.
artículo científico publicado en 1997
Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms
artículo científico publicado en 2008
Renal toxicity associated with tenofovir use.
artículo científico publicado en 2010
Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: which works better?
artículo científico publicado en 2003
Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy
artículo científico publicado en 2003
Reply to Pascual Pareja et al
scientific article published in 2009
Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016.
artículo científico publicado en 2016
Reproductive options for HIV-serodiscordant couples.
artículo científico publicado en 2006
Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience
artículo científico publicado en 2011
Resistance in hepatitis B virus
artículo científico publicado en 2008
Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinations.
artículo científico publicado en 2002
Resistance to HIV protease inhibitors: mechanisms and clinical consequences
artículo científico publicado en 2004
Resistance to antiretroviral agents in individuals with HIV-1 non-B subtypes
artículo científico publicado en 2002
Resistance to entry inhibitors
Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain
scientific article published on 29 September 2005
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
⬇️
artículo científico publicado el 29 de abril de 2013
Retreatment for 24 vs 48 weeks with interferon-alpha2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon alone.
artículo científico publicado en 2000
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
artículo científico publicado en 2013
Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection
artículo científico publicado en 2012
Risk for immune-mediated liver reactions by nevirapine revisited.
artículo científico publicado en 2008
Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir
artículo científico publicado en 2005
Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients
article
Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients
artículo científico publicado en 2005
Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy
artículo científico publicado en 2000
Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions
artículo científico publicado en 2008
Role of Nonnucleosides in the Development of HAART-Related Lipid Disturbances
⬇️
artículo científico publicado el 15 de diciembre de 2001
Role of atazanavir in the treatment of HIV infection
artículo científico publicado en 2009
Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.
artículo científico publicado en 2003
Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy
artículo científico publicado en 2002
Role of tenofovir in HIV and hepatitis C virus coinfection
artículo científico publicado en 2008
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial
artículo científico publicado en 2007
SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals
scientific article published on 01 May 2002
SENV infection in HIV-positive patients: prevalence, subtype characterization, and impact on HIV disease progression
artículo científico publicado en 2003
SOLAR-2: the sun also rises for cirrhotics.
artículo científico publicado en 2016
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study
artículo científico publicado en 2012
Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients
artículo científico publicado en 2010
Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir
⬇️
artículo científico publicado el 1 de diciembre de 1997
Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience
artículo científico publicado en 2016
Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families
artículo científico publicado en 2002
Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain
artículo científico publicado en 2013
Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana.
artículo científico publicado en 2019
Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.
artículo científico publicado en 2007
Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.
artículo científico publicado en 2013
Sequence Note: Genetic Analysis of Human Immunodeficiency Virus Type 2 Strains from Spain
⬇️
artículo científico publicado el 1 de enero de 1998
Serological markers of human immunodeficiency virus infection in African patients with AIDS: are they different from markers found in patients from other countries?
artículo científico publicado en 1988
Seroprevalence of HTLV infection among immigrant pregnant women in the Mediterranean coast of Spain.
artículo científico publicado en 2011
Seroprevalence of HTLV infection in Spain among immigrant pregnant women
artículo científico publicado en 2011
Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain
scientific article published on June 2009
Seroreversion in patients with end-stage HIV infection.
artículo científico publicado en 1994
Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART.
artículo científico publicado en 2006
Seroreversion of hepatitis C virus (HCV) antibodies in an HIV-infected patient despite continuous HCV replication
artículo científico publicado en 2009
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs
artículo científico publicado en 2006
Severe myopathy in an injection drug user coinfected with human immunodeficiency virus type 1 and human T cell leukemia virus type II.
artículo científico publicado en 1994
Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients
artículo científico publicado en 2008
Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy.
artículo científico publicado en 2015
Short Communication: Use of Serum Bilirubin Levels as Surrogate Marker of Early Virological Response to Atazanavir-Based Antiretroviral Therapy
scientific article published on 23 March 2011
Short article: Hepatitis delta in patients with resolved hepatitis B virus infection
artículo científico publicado en 2018
Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells
scientific article published on 21 September 2011
Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B?
artículo científico publicado en 2012
Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses
artículo científico publicado en 2012
Short communication: benefits in the lipid profile after substitution of abacavir for Stavudine: a 48-week prospective study
artículo científico publicado en 2004
Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients
artículo científico publicado en 2003
Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection
artículo científico publicado en 2004
Short communication: severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regions
artículo científico publicado en 2011
Short communication: transmission of hepatitis B viruses with lamivudine resistance mutations in newly diagnosed HIV individuals
artículo científico publicado en 2009
Should HIV Patients be concerned about Occult Hepatitis B?
artículo científico publicado en 2018
Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third-generation RIBA assay and PCR.
artículo científico publicado en 1994
Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk.
artículo científico publicado en 1997
Significance of positive polymerase chain reaction results in HIV-seronegative individuals
artículo científico publicado en 1992
Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain
scientific article published on 01 April 1990
Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trial
artículo científico publicado en 2010
Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI use.
artículo científico publicado en 2002
Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.
artículo científico publicado en 2005
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
artículo científico publicado en 1999
Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy
artículo científico publicado en 2011
Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results
artículo científico publicado en 2007
Spanish consensus conference on drug resistance testing in clinical practice. HIV drug resistance Spanish panel.
artículo científico publicado en 1999
Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.
artículo científico publicado en 2014
Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe
artículo científico publicado en 2008
Stability of hepatitis C virus (HCV) RNA levels among interferon‐naïve HIV/HCV‐coinfected individuals treated with combination antiretroviral therapy
⬇️
artículo científico publicado el 27 de marzo de 2013
Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008.
artículo científico publicado en 2008
Strategic use of lamivudine in the management of chronic hepatitis B.
artículo científico publicado en 2013
Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir
artículo científico publicado en 2006
Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola
artículo científico publicado en 2008
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors
artículo científico publicado en 2006
Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption
artículo científico publicado en 2005
Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells
artículo científico publicado en 2008
Survival of HIV-infected patients with compensated liver cirrhosis
article
Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide
artículo científico publicado en 2006
Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy
artículo científico publicado en 2006
Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients
artículo científico publicado en 2006
Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.
artículo científico publicado en 2013
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy.
artículo científico publicado en 2010
Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring
artículo científico publicado en 2008
Synthetic peptide immunoassay for diagnosis of HIV 2 infection
scientific article published on 01 January 1989
Synthetic peptide immunoassay in diagnosis of primary HIV infection.
artículo científico publicado en 1990
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment
artículo científico publicado en 2007
T regulatory cells and HIV infection.
artículo científico publicado en 2007
TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients
artículo científico publicado en 2015
Telbivudine: a new option for the treatment of chronic hepatitis B.
artículo científico publicado en 2007
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA.
artículo científico publicado en 2013
Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption.
artículo científico publicado en 2010
Tenofovir for Hepatitis Delta
artículo científico publicado en 2015
Tenofovir-related nephrotoxicity in HIV-infected patients
artículo científico publicado en 2004
Tests for HIV in lupus
scientific article published on 01 September 1994
The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes
article
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support
⬇️
artículo científico publicado el 1 de mayo de 1998
The benefit of simplification from tipranavir/ritonavir 500/200 bid to 500/100 bid guided by therapeutic drug monitoring
artículo científico publicado en 2010
The challenge of the new H1N1 influenza A
artículo científico publicado en 2009
The changing epidemiology of liver disease in HIV patients.
artículo científico
The changing face of hepatitis C in the new era of direct-acting antivirals.
artículo científico publicado en 2012
The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load
artículo científico publicado en 1998
The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors
scientific article published on 01 November 2011
The global spread of HIV-1 subtype B epidemic
artículo científico publicado en 2016
The implications of antiviral drugs with activity against hepatitis B virus and HIV.
artículo científico publicado en 2007
The role of CD8+ T-cell response in HIV infection.
artículo científico publicado en 2004
The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals.
artículo científico publicado en 2005
The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies.
artículo científico publicado en 2009
The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women
artículo científico publicado en 2005
Third-generation recombinant immunoblot assay to confirm hepatitis C virus-indeterminate serological samples.
artículo científico publicado en 1993
Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients
article
Tolerability of abacavir in the clinical setting
artículo científico publicado en 2000
Tolerance of didanosine as enteric-coated capsules versus buffered tablets.
artículo científico publicado en 2004
Towards hepatitis C eradication from the HIV-infected population
artículo científico publicado en 2014
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
artículo científico publicado en 2009
Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor
scientific article published on 01 June 2003
Transmission of Multi-Drug Resistant HIV-1 Despite Antiretroviral Prophylaxis
artículo científico publicado en 2017
Treatment and prevention of HIV infection with long-acting antiretrovirals
artículo científico publicado en 2018
Treatment failure with new hepatitis C drugs
artículo científico
Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future
artículo científico publicado en 2003
Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis
artículo científico publicado en 2007
Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis
artículo científico publicado en 2010
Treatment of chronic hepatitis C in HIV-infected patients with interferon alpha-2b plus ribavirin.
artículo científico publicado en 2003
Treatment of chronic hepatitis C in HIV-positive individuals: selection of candidates
artículo científico publicado en 2005
Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?
artículo científico publicado en 2003
Treatment of hepatitis C in HIV patients in the new DAA era.
artículo científico publicado en 2014
Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
artículo científico publicado en 2012
Treatment of hepatitis C with new fixed dose combinations
artículo científico publicado en 2017
Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
artículo científico publicado en 2019
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study
artículo científico publicado en 2016
Treatment response and drug resistance in patients infected with HIV type 1 group O viruses
artículo científico publicado en 2005
Treatment with Raltegravir, a retroviral integrase inhibitor, in patients infected with HTLV-1.
artículo científico publicado en 2011
Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements
artículo científico publicado en 2008
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain
⬇️
artículo científico publicado el 23 de marzo de 2012
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir
artículo científico publicado en 2013
Tropism, Coreceptor Use, and Phylogenetic Analysis of Both the V3 Loop and the Protease Gene of Three Novel HIV-1 Group O Isolates
⬇️
artículo científico publicado el 15 de agosto de 1998
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
artículo científico publicado en 2008
Update of the DHHS antiretroviral treatment guidelines
artículo científico publicado en 2014
Update on HIV/HCV coinfection.
artículo científico
Update on the treatment of chronic hepatitis C in HIV-infected patients
artículo científico publicado en 2007
Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
artículo científico publicado en 2008
Use of different inhibitory quotients to predict early virological response to tipranavir in antiretroviral-experienced human immunodeficiency virus-infected patients.
artículo científico publicado en 2009
Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701.
artículo científico publicado en 2010
Usefulness of genotypic analysis of resistance to nucleoside analogues in the clinical setting.
artículo científico publicado en 1999
Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C.
scientific article published on 17 October 2008
Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards
artículo científico publicado en 2007
Variability in the P6gag domains of HIV-1 involved in viral budding
artículo científico publicado en 2006
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes
artículo científico publicado en 2011
Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection.
artículo científico publicado en 2013
Very late HCV relapse following triple therapy for hepatitis C.
artículo científico publicado en 2014
Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.
artículo científico publicado en 2013
Viral hepatitis and HIV co-infection
artículo científico publicado en 2009
Viral hepatitis: Treating hepatitis C in injection drug users
artículo científico publicado en 2013
Viral resistance and genetic barrier of atazanavir
artículo científico publicado en 2008
Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment
artículo científico publicado en 2002
Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.
artículo científico publicado en 2006
Virus load and cytolitic responses in human immunodeficiency virus infection: what is cause and what is effect
artículo científico publicado en 2003
Visceral leishmaniasis in patients infected with the human immunodeficiency virus
⬇️
artículo científico publicado el 1 de diciembre de 1997
Weight loss in HIV-infected patients
artículo científico publicado en 2002
What dual protease inhibitor combination for salvage therapies?
scientific article published on 01 October 1999
When and how to use maraviroc in HIV-infected patients
artículo científico publicado en 2009
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
artículo científico publicado en 2008
Why such excess of mortality for COVID-19 in Spain?
artículo científico publicado en 2020
X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain
artículo científico publicado en 2014
[Acute hepatitis B in a previously vaccinated patient infected by the human immunodeficiency virus]
scientific article published on 01 October 2001
[Antiretroviral therapy in HIV infection: how long its efficacy?]
scientific article published on 01 February 2006
[Diagnosis of HIV-1 non-B subtypes and HIV-2]
artículo científico publicado en 2008
[Healthcare resources restrictions and human immunodeficiency virus infection]
artículo científico publicado en 2013
[Hepatitis B in 2008]
artículo científico publicado en 2008
[Intensification of antiretroviral treatment]
scientific article published on 01 February 2000
[Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy]
artículo científico publicado en 2009
[Regulation of transcription in different HIV-1 subtypes]
artículo científico publicado en 2005
[Reproductive advice in HIV-discordant couples]
artículo científico publicado en 2007
[Resistance to integrase inhibitors].
artículo científico publicado en 2008
[Simplification of the antiretroviral regimens. A need to guarantee the long-term control of HIV infection]
scientific article published on 01 April 2004
[Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program]
artículo científico publicado en 2000
[XMRV, a new human retrovirus for disease]
artículo científico publicado en 2011
Infecciones por el virus de la inmunodeficiencia humana tipo 2 y por los virus linfotrópicos de células T humanas en España
⬇️
artículo científico publicado el 6 de septiembre de 2013
Infección por el VIH-2, virus linfotrópico de células T y nuevos retrovirus humanos en España
⬇️
artículo científico publicado el 11 de mayo de 2011